Skip to main content
An official website of the United States government
Email

Acknowledgments

The President’s Cancer Panel is grateful to all participants who invested their time in the series of workshops on cancer screening and to the members of the Working Group on Cancer Screening During the COVID-19 Era, who guided workshop planning (see Series Information). The Panel is especially thankful to the following Working Group members who chaired subcommittees for each of the cancer types covered in the series.

  • Al B. Benson, III, MD, FACP, FASCO, Northwestern University Feinberg School of Medicine
  • V. Paul Doria-Rose, DVM, PhD, National Cancer Institute
  • Kevin S. Hughes, MD, FACS, Medical University of South Carolina
  • Worta McCaskill-Stevens, MD, National Cancer Institute
  • Rebecca Perkins, MD, Boston University School of Medicine/Boston Medical Center
  • Mitchell D. Schnall, MD, PhD, University of Pennsylvania Perelman School of Medicine
  • Richard C. Wender, MD, University of Pennsylvania Perelman School of Medicine
  • Nicolas Wentzensen, MD, PhD, MS, National Cancer Institute

The Panel appreciates the thoughtful comments provided by the following individuals who shared their expertise and/or provided feedback on early drafts of the report. Acknowledgment of the important role of these reviewers should not be interpreted as endorsement of the Panel’s positions or recommendations.

  • Elise S. Anthony, JD, Office of the National Coordinator for Health Information Technology
  • Ryan Argentieri, MBA, Office of the National Coordinator for Health Information Technology
  • Tracy Battaglia, MD, MPH, Boston University Schools of Medicine and Public Health
  • Sarah Coles, MD, Banner Health
  • Anjelica Davis, MPPA, Fight Colorectal Cancer
  • Chyke A. Doubeni, MBBS, MPH, Mayo Clinic
  • Venus Ginés, MA, P/CHWI, Día de la Mujer Latina
  • Heather Hampel, MS, LGC, The Ohio State University College of Medicine
  • Kathy J. Helzlsouer, MD, MHS, National Cancer Institute
  • Paul Jacobsen, PhD, National Cancer Institute
  • Nilesh Kalyanaraman, MD, Anne Arundel County Department of Health
  • Warren A. Kibbe, PhD, Duke University
  • Bron Kisler, CDISC
  • Alex H. Krist, MD, MPH, Virginia Commonwealth University
  • Edwin Lomotan, MD, Agency for Healthcare Research and Quality
  • Thomas A. Mason, MD, Office of the National Coordinator for Health Information Technology
  • Folasade P. May, MD, PhD, MPhil, UCLA Health
  • Maria Michaels, MBA, PMP, Centers for Disease Control and Prevention
  • Elisabeth Myers, MBA, Office of the National Coordinator for Health Information Technology
  • Lori A. Orlando, MD, MHS, Duke University School of Medicine
  • Steven Posnack, MS, MHS, Office of the National Coordinator for Health Information Technology
  • Mona Saraiya, MD, MPH, Centers for Disease Control and Prevention
  • Avinash Shanbhag, MS, Office of the National Coordinator for Health Information Technology
  • Mario Teran, MD, Agency for Healthcare Research and Quality

The Panel also acknowledges the efforts and contributions of Panel staff and support staff:

  • Janet Braun, CMP
  • Daniel Eckstein, MA
  • Samantha L. Finstad, PhD
  • Rebecca Hardesty, PhD
  • Randi LW Hays
  • William Huggins
  • Maureen Johnson, PhD
  • Brian Johnson, PhD
  • Erin Milliken, PhD
  • Benjamin Neal
  • Katherine Nicol, MS
  • Jennifer Owers
  • Catherine A. Schweppe, PhD
  • Scott Wheeler, MS
  • Rachel Wojnilower
  • Dana Young, JD
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Acknowledgments was originally published by the National Cancer Institute.”

Email